Independent Research analyst Bernhard Weininger maintained a Hold rating on Pfizer (NYSE: PFE) yesterday and set a price target of $48. The company’s shares closed yesterday at $44.70, close to its 52-week high of $44.84.
Currently, the analyst consensus on Pfizer is a Moderate Buy with an average price target of $46.91, representing a 4.9% upside. In a report issued on September 26, Barclays also maintained a Hold rating on the stock with a $40 price target.
The company has a one-year high of $44.84 and a one-year low of $33.20. Currently, Pfizer has an average volume of 19.31M.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.